Published in Gene Therapy Weekly, December 26th, 2002
Scientists in Seattle, Washington, have developed such a vector and tested its efficacy in animals for more than a year. Their findings indicate the vector would be suitable for therapies combining gene transfer with stem cell implantation.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.